Loading...

Global Nuclear Demand Will Secure Long-Term Value

Published
10 Nov 24
Updated
27 Sep 25
AnalystConsensusTarget's Fair Value
CA$116.94
0.6% overvalued intrinsic discount
27 Sep
CA$117.59
Loading
1Y
82.0%
7D
-1.4%

Author's Valuation

CA$116.940.6% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on27 Sep 25
Fair value Increased 1.91%

Cameco’s consensus revenue growth forecast has markedly increased from 2.6% to 3.4% per annum, supporting a modest upward revision in the analyst price target from CA$114.75 to CA$116.94. What's in the News Cameco finalized a multi-year agreement to supply natural uranium hexafluoride (UF6) to Slovenske elektrarne, ensuring a secure uranium source for Slovakia’s Bohunice and Mochovce nuclear plants through 2036 (Key Developments, 2025-09-12).

Shared on30 Aug 25
Fair value Increased 1.83%

Cameco’s consensus revenue growth forecast has edged down from 2.8% to 2.6% per annum while net profit margin remains steady, resulting in a marginal increase in its analyst price target from CA$112.69 to CA$114.75. What's in the News Cameco and Orano Canada signed a 15-year, $500 million workforce transportation agreement with Indigenous-owned Rise Air to support northern Saskatchewan operations, marking the largest and longest partnership with the airline.

Shared on04 Aug 25
Fair value Increased 10%

Despite a notable decline in consensus revenue growth forecasts and a higher future P/E ratio, Cameco's consensus analyst price target has been raised from CA$102.38 to CA$110.12. What's in the News Heidi Shockey will be appointed as chief financial officer effective September 1, 2025, as part of succession planning.

Shared on01 May 25
Fair value Increased 19%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.98%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.64%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 14%

AnalystConsensusTarget has increased revenue growth from 7.1% to 8.3%.

Shared on12 Mar 25
Fair value Increased 4.97%